Market Overview

Earnings Outlook For Enzo Biochem


Enzo Biochem (NYSE: ENZ) unveils its next round of earnings Tuesday. Get prepared with Benzinga's ultimate preview for Enzo Biochem's Q2 earnings.

Earnings and Revenue

Enzo Biochem EPS is expected to be around a loss of 1 cent, according to sell-side analysts. Sales will likely be near $27.35 million.

In the same quarter last year, Enzo Biochem reported a loss per share of 2 cents on revenue of $26.26 million. If the company were to report inline earnings when it publishes results Tuesday, sales would be up 4.15 percent on a year-over-year basis.

Enzo Biochem's reported EPS has stacked up against analyst estimates in the past like this:


Quarter Q1 2018 Q4 2017 Q3 2017 Q2 2017
EPS Estimate -0.01 -0.02 -0.03 -0.04
EPS Actual -0.01 -0.04 0 -0.02


Stock Performance

Over the last 52-week period, shares are up 6.52 percent. Given that these returns are generally positive, long-term shareholders are probably satisfied going into this earnings release.

Over the past 90 days, analysts have adjusted their estimates higher for EPS and revenues. The popular rating by analysts on Enzo Biochem stock is a Neutral. The strength of this rating has maintained conviction over the past 90 days.

Conference Call

Enzo Biochem's Q2 conference call is scheduled to begin at 8:30 a.m. ET.


Related Articles (ENZ)

View Comments and Join the Discussion!

Posted-In: Earnings News Previews Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at